Literature DB >> 15839723

Cognitive impairment as determinant for sub-optimal control of oral anticoagulation treatment in elderly patients with atrial fibrillation.

Bob A J van Deelen1, Patricia M L A van den Bemt, Toine C G Egberts, Annelies van 't Hoff, Huub A A M Maas.   

Abstract

BACKGROUND AND
OBJECTIVE: Atrial fibrillation is an indication for oral anticoagulation treatment. Maintaining the International Normalized Ratio (INR) within the therapeutic range minimises thromboembolic and bleeding complications. We have investigated whether cognitive capacity affects control of anticoagulation in elderly patients with atrial fibrillation. PATIENTS AND METHODS: A retrospective study was conducted to investigate the association between cognitive impairment and control of anticoagulation. Patients > or =70 years of age with atrial fibrillation using acenocoumarol (nicoumalone) as anticoagulant were included. All patients were monitored by the Anticoagulation Clinic in the Midden-Brabant region in the Netherlands. The cognitive function of all patients was assessed using the Mini-Mental State Examination (MMSE) on the index date. INR values were obtained from the year preceding the index date. Patients with an MMSE score <23 were defined as cognitively impaired. The primary outcome of the study was the incidence of an INR value within the therapeutic range of 2.0-3.4 during < or =70% of treatment time in the year prior to the cognitive function assessment. The secondary endpoint was the number of patients with an INR <2.0 or > or =6.0 at least once during this year. Logistic regression analysis was used to evaluate the association between cognitive function and control of anticoagulation.
RESULTS: A total of 152 patients were included in the study. An MMSE score <23 was associated with an inadequate INR control (odds ratio [OR] 2.77; 95% CI 1.13, 6.74). After correction for hospital admission and change of possibly interacting medication (both also associated with inadequate INR control), this association remained statistically significant. Significantly more patients with an MMSE score <23 had one or more INR values of six or higher (OR 3.06; 95% CI 1.14, 8.18).
CONCLUSION: In elderly people with atrial fibrillation using oral anticoagulation, an MMSE score <23 is independently associated with an inadequate INR control, mainly because of an increased number of supratherapeutic INR values. This finding should be taken into account when making decisions about use of oral anticoagulants in the elderly.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15839723     DOI: 10.2165/00002512-200522040-00007

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  35 in total

1.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study.

Authors:  A Ott; M M Breteler; M C de Bruyne; F van Harskamp; D E Grobbee; A Hofman
Journal:  Stroke       Date:  1997-02       Impact factor: 7.914

Review 2.  Atrial fibrillation in the elderly: anticoagulation strategies and indications in the very elderly.

Authors:  Sridar Kamath; Gregory Y H Lip
Journal:  Am J Geriatr Cardiol       Date:  2002 Nov-Dec

3.  Atrial fibrillation and stroke prevention with warfarin in the long-term care setting.

Authors:  J H Gurwitz; J Monette; P A Rochon; M A Eckler; J Avorn
Journal:  Arch Intern Med       Date:  1997-05-12

4.  Mini-mental state examination and mental deterioration battery: analysis of the relationship and clinical implications.

Authors:  Patrizio Pasqualetti; Filomena Moffa; Paola Chiovenda; Giovanni A Carlesimo; Carlo Caltagirone; Paolo M Rossini
Journal:  J Am Geriatr Soc       Date:  2002-09       Impact factor: 5.562

5.  Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation.

Authors:  F J Penning-van Beest; E van Meegen; F R Rosendaal; B H Stricker
Journal:  Thromb Haemost       Date:  2001-08       Impact factor: 5.249

6.  Therapeutic control of oral anticoagulant treatment in The Netherlands.

Authors:  A M van den Besselaar; F J van der Meer; C W Gerrits-Drabbe
Journal:  Am J Clin Pathol       Date:  1988-12       Impact factor: 2.493

7.  Warfarin use among patients with atrial fibrillation.

Authors:  L M Brass; H M Krumholz; J M Scinto; M Radford
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

8.  Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

Authors:  E Chiquette; M G Amato; H I Bussey
Journal:  Arch Intern Med       Date:  1998 Aug 10-24

Review 9.  Anticoagulation in the elderly.

Authors:  Abhay J Dhond; Hector I Michelena; Michael D Ezekowitz
Journal:  Am J Geriatr Cardiol       Date:  2003 Jul-Aug

10.  A method to determine the optimal intensity of oral anticoagulant therapy.

Authors:  F R Rosendaal; S C Cannegieter; F J van der Meer; E Briët
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

View more
  12 in total

1.  The effect of cognitive impairment in the elderly on the initial and long-term stability of warfarin therapy.

Authors:  Hanan S Khreizat; Peter Whittaker; Kristy D Curtis; Gerald Turlo; Candice L Garwood
Journal:  Drugs Aging       Date:  2012-04-01       Impact factor: 3.923

Review 2.  Recommendations to prescribe in complex older adults: results of the CRIteria to assess appropriate Medication use among Elderly complex patients (CRIME) project.

Authors:  Graziano Onder; Francesco Landi; Domenico Fusco; Andrea Corsonello; Matteo Tosato; Miriam Battaglia; Simona Mastropaolo; Silvana Settanni; Manuela Antocicco; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2014-01       Impact factor: 3.923

3.  Medication management capacity in relation to cognition and self-management skills in older people on polypharmacy.

Authors:  C G M Sino; M Sietzema; T C G Egberts; M J Schuurmans
Journal:  J Nutr Health Aging       Date:  2014-01       Impact factor: 4.075

4.  Geriatric Elements and Oral Anticoagulant Prescribing in Older Atrial Fibrillation Patients: SAGE-AF.

Authors:  Jane S Saczynski; Saket R Sanghai; Catarina I Kiefe; Darleen Lessard; Francesca Marino; Molly E Waring; David Parish; Robert Helm; Felix Sogade; Robert Goldberg; Jerry Gurwitz; Weijia Wang; Tanya Mailhot; Benita Bamgbade; Bruce Barton; David D McManus
Journal:  J Am Geriatr Soc       Date:  2019-10-01       Impact factor: 5.562

5.  Changes in under-treatment after comprehensive geriatric assessment: an observational study.

Authors:  Linda R Tulner; Jos P C M van Campen; Suzanne V Frankfort; Cornelis H W Koks; Jos H Beijnen; Desiderius P M Brandjes; Paul A F Jansen
Journal:  Drugs Aging       Date:  2010-10-01       Impact factor: 3.923

Review 6.  Reasons for undertreatment with oral anticoagulants in frail geriatric outpatients with atrial fibrillation: a prospective, descriptive study.

Authors:  Linda R Tulner; Jos P C M Van Campen; Ingeborg M J A Kuper; George J P T Gijsen; Cornelis H W Koks; Melvin R Mac Gillavry; Harm van Tinteren; Jos H Beijnen; Desiderius P M Brandjes
Journal:  Drugs Aging       Date:  2010-01-01       Impact factor: 3.923

7.  Cognitive function and adherence to anticoagulation treatment in patients with atrial fibrillation.

Authors:  Beata Jankowska-Polańska; Lomper Katarzyna; Alberska Lidia; Jaroch Joanna; Krzysztof Dudek; Uchmanowicz Izabella
Journal:  J Geriatr Cardiol       Date:  2016-07       Impact factor: 3.327

8.  Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study.

Authors:  Mette Søgaard; Flemming Skjøth; Martin Jensen; Jette Nordstrøm Kjældgaard; Gregory Y H Lip; Torben Bjerregaard Larsen; Peter Brønnum Nielsen
Journal:  J Am Heart Assoc       Date:  2019-05-29       Impact factor: 5.501

9.  Geriatric Syndromes and Atrial Fibrillation: Prevalence and Association with Anticoagulant Use in a National Cohort of Older Americans.

Authors:  Sachin J Shah; Margaret C Fang; Sun Y Jeon; Steven E Gregorich; Kenneth E Covinsky
Journal:  J Am Geriatr Soc       Date:  2020-09-28       Impact factor: 5.562

10.  Safety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary care.

Authors:  Jean-François Chenot; Thanh Duc Hua; Manar Abu Abed; Hannelore Schneider-Rudt; Tim Friede; Simon Schneider; Stefan Viktor Vormfelde
Journal:  BMC Fam Pract       Date:  2014-05-25       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.